BSTG
Price:
$4.03
Market Cap:
$57.82M
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
Industry
Biotechnology
IPO Date
2013-10-21
Stock Exchange
OTC
Ticker
BSTG
According to Biostage, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.20. This represents a change of -32.86% compared to the average of -9.23 of the last 4 quarters.
The mean historical PE Ratio of Biostage, Inc. over the last ten years is -3.20. The current -6.20 PE Ratio has changed 19.29% with respect to the historical average. Over the past ten years (40 quarters), BSTG's PE Ratio was at its highest in in the September 2015 quarter at -0.00. The PE Ratio was at its lowest in in the September 2022 quarter at -19.98.
Average
-3.20
Median
-1.96
Minimum
-10.28
Maximum
-0.01
Discovering the peaks and valleys of Biostage, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.08%
Maximum Annual PE Ratio = -0.01
Minimum Annual Increase = -42.69%
Minimum Annual PE Ratio = -10.28
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.56 | 28.24% |
| 2023 | -5.89 | -42.69% |
| 2022 | -10.28 | 254.35% |
| 2021 | -2.90 | 28.38% |
| 2020 | -2.26 | 35.78% |
| 2019 | -1.66 | 36.27% |
| 2018 | -1.22 | 784.95% |
| 2017 | -0.14 | 124.68% |
| 2016 | -0.06 | 1.08% |
| 2015 | -0.01 | -7.60% |
The current PE Ratio of Biostage, Inc. (BSTG) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.91
5-year avg
-5.78
10-year avg
-3.20
Biostage, Inc.’s PE Ratio is greater than Herantis Pharma Oyj (-9.50), less than Oncopeptides AB (publ) (-4.57), less than Mindset Pharma Inc. (-4.01), less than Karolinska Development AB (publ) (-0.68), less than Medivir AB (publ) (-4.51), greater than Abliva AB (publ) (-9.56), less than E-therapeutics Plc (-5.10), less than Relief Therapeutics Holding AG (-2.03), less than Goodness Growth Holdings, Inc. (-6.01), less than MCI Onehealth Technologies Inc. (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.50 | $59.47M | |
| -4.57 | $55.98M | |
| -4.01 | $54.51M | |
| -0.68 | $68.85M | |
| -4.51 | $45.78M | |
| -9.56 | $45.13M | |
| -5.10 | $75.96M | |
| -2.03 | $44.94M | |
| -6.01 | $61.05M | |
| 0 | $54.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biostage, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biostage, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biostage, Inc.'s PE Ratio?
How is the PE Ratio calculated for Biostage, Inc. (BSTG)?
What is the highest PE Ratio for Biostage, Inc. (BSTG)?
What is the 3-year average PE Ratio for Biostage, Inc. (BSTG)?
What is the 5-year average PE Ratio for Biostage, Inc. (BSTG)?
How does the current PE Ratio for Biostage, Inc. (BSTG) compare to its historical average?